State v. Stubbs

304 P.3d 40, 256 Or. App. 817, 2013 WL 2363240, 2013 Ore. App. LEXIS 651
CourtCourt of Appeals of Oregon
DecidedMay 30, 2013
DocketD094960T; A145851
StatusPublished
Cited by1 cases

This text of 304 P.3d 40 (State v. Stubbs) is published on Counsel Stack Legal Research, covering Court of Appeals of Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State v. Stubbs, 304 P.3d 40, 256 Or. App. 817, 2013 WL 2363240, 2013 Ore. App. LEXIS 651 (Or. Ct. App. 2013).

Opinion

NAKAMOTO, J.

Defendant was convicted after a jury trial of one count of driving under the influence of intoxicants (DUII), a misdemeanor. ORS 813.010.1 After the court gave its jury instructions but before deliberations had begun, a juror asked the court whether Ambien, a central nervous system depressant, was a controlled substance. In response, the court did not answer the juror’s question and instead indicated that the jury was to proceed to deliberations, having heard all the evidence and the jury instructions. On appeal, defendant assigns error to the trial court’s failure to instruct the jury further that defendant’s Ambien use was irrelevant to the case. First, defendant asserts that the state prosecuted him on the theory that he had used narcotics and was impaired by narcotics, not Ambien. Second, defendant suggests that, although there was evidence that Ambien is a controlled substance, the state failed to establish, as a matter of law, that defendant was impaired by Ambien. Third, defendant argues that, given the state’s theory and the evidence at trial, the trial court was required to instruct the jury that Ambien was not a relevant controlled substance when it became clear that the jury might consider defendant’s use of Ambien as a basis upon which to convict him. For the following reasons, we affirm.

We take the following facts from the record. Officer Hyson was on patrol in the morning when he saw defendant drive through an intersection without stopping at a stop sign. After Hyson pulled over defendant, he asked for defendant’s license, registration, and proof of insurance. After Hyson repeated his request for the three documents, defendant appeared to have difficulty retrieving his license from his wallet. Hyson noticed that defendant’s speech was slow and slightly slurred.

[819]*819Shortly after Hyson stopped defendant, he became concerned that defendant was having medical problems or was impaired by medication. After denying any immediate medical problems, defendant agreed to take field sobriety tests. When defendant got out of his car, he swayed and stumbled such that Hyson had to place his hand on defendant’s arm until defendant was able to regain his balance. Hyson then administered three field sobriety tests to defendant. Hyson first administered the horizontal gaze nystagmus (HGN) test, an eye examination developed to detect intoxication. Hyson observed nystagmus and six out of the six possible “clues” indicating intoxication. During the HGN test, Hyson did not note the size of defendant’s pupils. For the “walk-and-turn” test, Hyson asked defendant to walk nine steps in a straight line in a heel-to-toe fashion and then return to the starting position. Defendant was unable to maintain the starting position, needing help from Hyson because he was swaying and stumbling, and then defendant could not walk in a straight line and almost fell when turning. Last, Hyson requested that defendant perform the “one-leg stand” test. Hyson instructed defendant to stand feet together, lift one foot at least six inches off the ground, and remain in that position for approximately 30 seconds. Defendant stated that no one could perform that test, and when defendant lifted his foot off the ground, he began to sway and stumble sideways. Hyson discontinued the test and arrested defendant for DUII.

At the jail, defendant agreed to provide a urine sample. Bessett, a criminalist at the Oregon State Police Crime Lab, analyzed defendant’s urine sample and prepared a written report. In his written report, Bessett confirmed the following substances present in defendant’s urine sample:

“Methadone, a Schedule II controlled substance and its metabolite EDDP[.]
“Oxycodone (Oxycontin, Percodan), a Schedule II controlled substance [.]
“Morphine, a Schedule II controlled substance and a metabolite of several opiates [.]
“Citalopram (Celexa) and/or escitalopram (Lexapro) both prescription controlled anti-depressants [.]”

[820]*820(Bullet points omitted.) Several days later, the state filed a traffic complaint for one count of DUII. The traffic complaint alleged that defendant was under the influence of “controlled substances” but did not specify which ones.

Bessett testified at trial. Before explaining the findings in his written report, he described his training. In part, he said that he had had training in drug classifications, and he described central nervous system depressants, such as Valium or Ambien, as an example of a drug classification. He also described the effects of a central nervous system depressant: it lowers a person’s heart rate, lowers a person’s breathing rate, and makes the person feel more relaxed.

With regard to the substances listed in Bessett’s report that were confirmed to be present in defendant’s urine, Bessett explained that methadone is a Schedule II controlled substance that is in the category of narcotic analgesics, which are considered depressants. Side effects of narcotic analgesics, he testified, may include confusion, disorientation, drowsiness, and mental clouding, and so narcotic analgesics may impair mental and physical capabilities. He explained that oxycodone, the active ingredient in Oxycontin and Percodan, and morphine are Schedule II controlled substances too and also are narcotic analgesics with side effects similar to methadone.2 Bessett explained the scheduling system for drugs and gave examples of drugs that would fall in each schedule, from Schedule I to Schedule V. Bessett’s example of a Schedule IV drug was Ambien. Bessett testified that methadone, oxycodone, and morphine are detectible in urine from two hours to two days after use. On cross-examination, Bessett testified that, generally, people under the influence of narcotics have “pinprick pupils” and do not display nystagmus when given the HGN test.

[821]*821To some extent, Bessett testified regarding defendant’s possible use of Ambien. He explained during direct examination that he was required to perform two tests on a urine sample: a screening test and a confirmation test. The screening test identifies the presence of a drug and its general type, e.g., narcotic. The next test, the confirming test, identifies the exact drug that is present in the urine sample. He then stated that, although the screening test had identified the presence of two other substances, Ambien and 7-amino Clonazepam, he was unable to find those again on the confirming test. During cross-examination, Bessett agreed that he was “not offering testimony that those other drugs [Ambien and 7-amino Clonazepam] were actually present because [he] didn’t confirm them.” Defense counsel then questioned Bessett regarding the narcotic analgesics that were confirmed to have been found in defendant’s urine sample.

In her redirect examination of Bessett, however, the prosecutor returned to the topic of Ambien. Bessett testified that, although narcotic analgesics do not typically cause nystagmus, which defendant exhibited during the HGN test, centralnervoussystemdepressants, such as Ambien, Clonazepam, and other drugs, do cause nystagmus.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Rudnitskyy v. State of Oregon
464 P.3d 471 (Court of Appeals of Oregon, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
304 P.3d 40, 256 Or. App. 817, 2013 WL 2363240, 2013 Ore. App. LEXIS 651, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-v-stubbs-orctapp-2013.